 |
市場調査レポート
商品コード
1086304
マルチプレックス診断の世界市場：製品タイプ別、用途別、エンドユーザー別、地域別 - 規模、シェア、展望、機会分析（2022年～2028年）Multiplexed Diagnostic Market, by Product Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
| マルチプレックス診断の世界市場：製品タイプ別、用途別、エンドユーザー別、地域別 - 規模、シェア、展望、機会分析（2022年～2028年） |
|
出版日: 2022年05月22日
発行: Coherent Market Insights
ページ情報: 英文 140 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
世界のマルチプレックス診断市場は、自己免疫疾患の有病率の上昇により、大きく牽引されています。
当レポートでは、世界のマルチプレックス診断市場について調査分析し、市場力学、動向分析、地域別分析、競合情勢などを提供しています。
目次
第1章 調査目的・前提条件
- 調査目的
- 前提条件
- 略語
第2章 市場の範囲
- レポートの説明
- 市場の定義と範囲
- エグゼクティブサマリー
- 市場内訳：製品別
- 市場内訳：用途別
- 市場内訳：エンドユーザー別
- 市場内訳：地域別
- Coherent Opportunity Map（COM）
第3章 市場力学・規制・動向分析
- 市場力学
- 促進要因
- 抑制要因
- 市場機会
- 規制シナリオ
- 業界動向
- 合併と買収
- 新製品の承認/発売
- プロモーションおよびマーケティングイニシアチブ
第4章 世界のマルチプレックス診断市場：製品別（2017年～2028年）
- イントロダクション
- 試薬・消耗品
- 器具
第5章 世界のマルチプレックス診断市場：用途別（2017年～2028年）
- イントロダクション
- 病気の診断
- 分子診断
- 医薬品開発
第6章 世界のマルチプレックス診断市場：エンドユーザー別（2017年～2028年）
- イントロダクション
- 病院
- 臨床研究所
- 学術機関・研究機関
- その他（製薬・診断研究所）
第7章 世界のマルチプレックス診断市場：地域別（2017年～2028年）
- イントロダクション
- 北米
- ラテンアメリカ
- 欧州
- アジア太平洋
- 中東
- アフリカ
第8章 競合情勢
- ヒートマップ分析
- 企業プロファイル
- Luminex Corporation
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Qiagen NV
- Abbott Laboratories
- Siemens Healthineers
- Agilent technologies
- BioMerieux SA
- F. Hoffmann-La Roche Ltd
- アナリストの見解
第9章 セクション
The multiplexed diagnostic assay is used to identify multiple analytes in a single run cycle. Multiplex assay is used in the detection of defects such as mutation in functional biomolecules (DNA, mRNA, and protein) with the help of DNA microarray, multiplex PCR, and next-generation sequencing. In multiplexed diagnostic market, multiplexed diagnostic assay is executed in research & diagnostic laboratories, hospitals, and drug development. Moreover, this multiplexed diagnostic tool is also used in the diagnosis of various diseases, infections, drug screening, and biomarkers.
Market Dynamics
The multiplexed diagnostic market is gaining significant traction due to rising prevalence of autoimmune diseases. For instance, according to the Centers for Disease Control and Prevention (CDC), the prevalence of arthritis from 2013 to 2015 was 54 million in the U.S. adults (22.7%) and by 2040, it is expected to reach 78 million (26%) in the U.S. adults of age 18 years or above. The data represent high prevalence of autoimmune diseases, indicating the need of advance diagnostic measures, which is expected to boost growth of the multiplexed diagnostic market over the forecast period.
Key features of the study:
- This report provides in-depth analysis of the global multiplexed diagnostic market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global multiplexed diagnostic market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Luminex Corporation, Thermo Fisher, Illumine Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Abbott Laboratories, Siemens Healthineers, Agilent technologies, BioMerieux SA, and F.Hoffmann-La Roche Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, product type up-gradation, market expansion, and marketing tactics
- The global multiplexed diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global multiplexed diagnostic market
Detailed Segmentation:
- Global Multiplexed Diagnostic Market, By Product Type:
- Reagents & Consumables
- Instruments
- Global Multiplexed Diagnostic Market, By Application:
- Disease Diagnostics
- Molecular Diagnostics
- Drug Development
- Global Multiplexed Diagnostic Market, By End User:
- Hospitals
- Clinical Laboratories
- Academic & Research Institutes
- Others
- Global Multiplexed Diagnostic Market, By Region:
- North America
? By Product Type:
? Reagents & Consumables
? Instruments
? By Application:
? Disease Diagnostics
? Molecular Diagnostics
? Drug Development
? By End User:
? Hospitals
? Clinical Laboratories
? Academic & Research Institutes
? Others
? By Country:
? U.S.
? Canada
- Latin America
? By Product Type:
? Reagents & Consumables
? Instruments
? By Application:
? Disease Diagnostics
? Molecular Diagnostics
? Drug Development
? By End User:
? Hospitals
? Clinical Laboratories
? Academic & Research Institutes
? Others
? By Country:
? Brazil
? Mexico
? Argentina
? Rest of Latin America
- Europe
? By Product Type:
? Reagents & Consumables
? Instruments
? By Application:
? Disease Diagnostics
? Molecular Diagnostics
? Drug Development
? By End User:
? Hospitals
? Clinical Laboratories
? Academic & Research Institutes
? Others
? By Country:
? Germany
? U.K.
? France
? Italy
? Spain
? Russia
? Rest of Europe
- Asia Pacific
? By Product Type:
? Reagents & Consumables
? Instruments
? By Application:
? Disease Diagnostics
? Molecular Diagnostics
? Drug Development
? By End User:
? Hospitals
? Clinical Laboratories
? Academic & Research Institutes
? Others
? By Country:
? China
? India
? Japan
? Australia
? South Korea
? ASEAN
? Rest of Asia Pacific
- Middle East
? By Product Type:
? Reagents & Consumables
? Instruments
? By Application:
? Disease Diagnostics
? Molecular Diagnostics
? Drug Development
? By End User:
? Hospitals
? Clinical Laboratories
? Academic & Research Institutes
? Others
? By Country:
? GCC
? Israel
? Rest of Middle East
- Africa
? By Product Type:
? Reagents & Consumables
? Instruments
? By Application:
? Disease Diagnostics
? Molecular Diagnostics
? Drug Development
? By End User:
? Hospitals
? Clinical Laboratories
? Academic & Research Institutes
? Others
? By Country/Region:
? South Africa
? Central Africa
? North Africa
- Company Profiles
- Luminex Corporation *
? Company Overview
? Material Portfolio
? Financial Performance
? Key Highlights
? Market Strategies
- Thermo Fisher
- Illumine Inc.
- Bio-Rad Laboratories, Inc.
- Qiagen N.V.
- Abbott Laboratories
- Siemens Healthineers
- Agilent technologies
- BioMerieux SA
- Hoffmann-La Roche Ltd.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet By Product
- Market Snippet By Application
- Market Snippet By End User
- Market Snippet By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Industry Trend
- Merger and Acquisitions
- New Product Approvals/Launch
- Promotion and Marketing Initiatives
4. Global Multiplexed Diagnostic Market, By Product, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-O-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Reagents & Consumables
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Instruments
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
5. Global Multiplexed Diagnostic Market, By Application, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-O-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Disease Diagnostic
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Molecular Diagnostic
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Drug Development
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
6. Global Multiplexed Diagnostic Market, By End User, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-O-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Clinical Laboratories
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Others (Pharmaceutical & Diagnostic Labs)
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
7. Global Multiplexed Diagnostic Market, By Regions, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
- Regional Trends
- North America
- Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Brazil
- Mexico
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Luminex Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Thermo Fisher Scientific, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Illumina, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Bio-Rad Laboratories, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Qiagen N.V.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Siemens Healthineers
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Agilent technologies
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- BioMerieux SA
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- F. Hoffmann-La Roche Ltd
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Analyst Views
9. Section
- References
- Research Methodology
- About us and Sales Contact
